olanzapine pamoate
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Olanzapine is one of the atypical antipsychotics widely used in the treatment of schizophrenia and has been associated with…
Sir, Nonadherence to oral antipsychotics is one of the greatest problems affecting treatment outcomes in patients with…
Abstract Aims: To determine the cost-effectiveness of long-acting injectable (LAI) antipsychotics for chronic schizophrenia in…
Objective Paliperidone palmitate long‐acting injection (PP‐LAI) has recently been approved for treatment of chronic schizophrenia…
Abstract Objective: Model validation is important, but seldom applied in chronic schizophrenia. Validation consists of verifying…
When treating schizophrenia and other psychotic disorders, clinicians often encounter the problems of non-adherence, which is…
The FDA is investigating the unexplained deaths of 2 patients who received intramuscular injections of olanzapine pamoate…
In the past two decades, there has been a small revolution in the treatment of schizophrenia and related psychoses. During the…